1. Prostate-specific antigen and detection of prostate cancer: What have we learned and what should we recommend for screening?

   • Christopher L. Amling

   OriginalPaper Pages: 337 - 345

2. Should finasteride be used to prevent prostate cancer?

   • Neil Fleshner
   • Girish Kulkarni

   OriginalPaper Pages: 346 - 354

3. Active surveillance versus radical treatment for favorable-risk localized prostate cancer

   • Laurence Klotz

   OriginalPaper Pages: 355 - 362

4. Testosterone therapy for men at risk for or with history of prostate cancer

   • Abraham Morgentaler

   OriginalPaper Pages: 363 - 369

5. Cytotoxic chemotherapy for prostate cancer: Who and when?

   • Rebecca A. Moss
   • Daniel P. Petrylak

   OriginalPaper Pages: 370 - 377

6. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer

   • Vicki L. Keedy
   • Jordan Berlin

   OriginalPaper Pages: 381 - 388

7. Metastatic colorectal cancer: Therapeutic options

   • Smitha Patiyil
   • Steven R. Alberts

   OriginalPaper Pages: 389 - 398

8. Liver-directed therapies for patients with primary liver cancer and hepatic metastases

   • Cletus A. Arciero
   • Elin R. Sigurdson

   OriginalPaper Pages: 399 - 409

9. Cancer of the gastroesophageal junction: Current therapy options

   • David H. Ilson

   OriginalPaper Pages: 410 - 423